HHS is a steal in the $6's imo. But I thought it looked pretty good in the high $7's. I added more shares today. Unless the new CEO is completely full of it (always a possibility), this is headed back to double digits. $6M in cost cuts this year, and another $10M next year. That'll only add to what was already a solid Q4 bottom line (excluding 1-times). So there's some big EPS coming. Like you said, might take a couple quarters to start putting up impressive GAAP earnings. But at least they'll have easy comps.
I'm a little disappointed we didn't see any insider buying this time. But maybe they're already in the blackout period with Q1 due next month.